Harpoon Therapeutics, Inc.

NASDAQ:HARP

23.01 (USD) • At close March 8, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Omzet 4.44820.2218.5834.08913.6178.3035.9064.3254.4845.8389.0077.4923.8932.7623.2972.2341.4171.0631.0631.0631.0631.0631.5630.708
Kosten van de omzet 0.2360.5681.1050.910.7060000000000000000000
Brutowinst 4.21219.6537.4783.17912.9118.3035.9064.3254.4845.8389.0077.4923.8932.7623.2972.2341.4171.0631.0631.0631.0631.0631.5630.708
Brutowinstmarge 0.9470.9720.8710.7770.9481111111111111111111
Onderzoek- en ontwikkelingskosten 12.32512.19615.16318.94720.97720.65120.81820.66416.97318.27116.21615.06513.05711.92412.51912.7069.5339.9719.3828.7175.9676.1515.5334.79
Algemene en administratieve kosten 4.2623.8034.1853.8544.5295.0635.4015.2024.1864.3354.6043.9244.4283.9453.9134.3338.4933.7345.8322.2151.9420.9670.9820.912
Verkoop- en marketingkosten 000000000000000000000000
Verkoop-, algemene en administratieve kosten 4.2623.8034.1853.8544.5295.0635.4015.2024.1864.3354.6043.9244.4283.9453.9134.3338.4933.7345.8322.2151.9420.9670.9820.912
Overige kosten 11.903-0.488-0.86-0.05-0.04-0.044-0.048-0.047-0.055-0.058-0.051-0.011-0.0140-0.0010.004-0.026-0.0150.04-0.008-0.0220-0.0020.075
Bedrijfskosten 16.58715.99919.34822.80125.50625.71426.21925.86621.15922.60620.8218.98917.48515.86916.43217.03918.02613.70515.21410.9327.9097.1186.5155.702
Bedrijfsresultaat -12.1392.493-10.765-18.712-11.889-17.411-20.313-21.541-16.675-16.768-61.767-11.497-13.592-13.107-13.135-14.805-16.609-12.642-14.151-9.869-6.846-6.055-4.952-4.994
Bedrijfsresultaat ratio -2.7290.123-1.254-4.576-0.873-2.097-3.439-4.981-3.719-2.872-6.858-1.535-3.491-4.745-3.984-6.627-11.721-11.893-13.312-9.284-6.44-5.696-3.168-7.054
Totaal overige inkomsten en kosten netto 10.337-2.217-0.5730.2920.2490.06-0.008-0.047-0.055-0.058-50.005-0.011-0.0140.415-0.0010.004-0.026-0.0150.04-0.008-0.022-0.005-0.0020.075
Inkomen voor belasting -1.8021.06-11.338-18.42-11.64-17.351-20.321-21.552-16.682-16.764-61.724-11.357-13.307-12.692-12.552-14.269-15.908-11.817-13.579-9.729-6.759-5.994-4.881-4.94
Inkomen voor belasting ratio -0.4050.052-1.321-4.505-0.855-2.09-3.441-4.983-3.72-2.872-6.853-1.516-3.418-4.595-3.807-6.387-11.227-11.117-12.774-9.152-6.358-5.639-3.123-6.977
Belastingkosten -0.2361.0710.711-0.345-0.249-0.060.008-0.036-0.048-0.06249.86-0.688-0.2990-0.584-1.032-0.531-1.139-0.532-0.205-0.109-0.061-0.0730.075
Nettowinst -1.8021.061-12.049-18.075-11.391-17.291-20.329-21.552-16.682-16.764-61.724-11.357-13.307-12.692-12.552-14.269-15.908-11.817-13.579-9.729-6.759-5.994-4.881-4.94
Nettowinstmarge -0.4050.052-1.404-4.42-0.837-2.083-3.442-4.983-3.72-2.872-6.853-1.516-3.418-4.595-3.807-6.387-11.227-11.117-12.774-9.152-6.358-5.639-3.123-6.977
WPA (Winst Per Aandeel) -0.460.3-3.26-5.37-3.45-5.23-6.18-6.6-5.1-5.2-19.5-4.5-5.3-5.1-5.1-5.8-6.5-4.9-9.2-4.07-7.15-6.34-5.17-0.52
Verwaterde WPA -0.460.3-3.26-5.37-3.45-5.23-6.18-6.6-5.1-5.2-19.5-4.5-5.3-5.1-5.1-5.8-6.5-4.9-9.2-4.07-7.15-6.34-5.17-0.52
EBITDA -12.1394.719-10.538-18.712-11.362-16.863-19.709-20.983-16.141-16.21938.69-11.497-13.062-12.595-12.632-14.805-16.609-12.642-13.854-9.729-6.687-5.901-4.813-4.818
EBITDA ratio -2.7290.233-1.228-4.576-0.834-2.031-3.337-4.852-3.6-2.7784.296-1.535-3.355-4.56-3.831-6.627-11.721-11.893-13.033-9.152-6.291-5.551-3.079-6.805